 | Amneal Pharmaceuticals, Inc. | |||
| NMS : AMRX || Location: United States | ||||
$5.87-0.03 (-0.51%) |
0.96 M | 5.84 - 5.97 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.804 M |
| March 28, 2024 | 2.398 M |
| March 15, 2024 | 2.069 M |
| Feb. 29, 2024 | 1.826 M |
| Feb. 15, 2024 | 2.096 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.09 | 0.14 | 54.19% |
| 09/30/2023 | 0.13 | 0.19 | 46.95% |
| 06/30/2023 | 0.11 | 0.19 | 75.76% |
| 03/31/2023 | 0.10 | 0.12 | 22.57% |
| 12/31/2022 | 0.21 | 0.23 | 7.73% |
AMRX Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 308.554M | Shares Float | 123.432M |
| Short Float | 2.804M | Market Cap | 1820.47M |
| Institution ownership | 29.17% | Insider ownership | 59.779% |
| Earnings Date | 05/03/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.47 | Forward EPS | 0.66 |